Since 1997, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and has spun out a new company every two months on average.
Over £2.1bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and eleven are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
High heat flux technology. The company will provide advanced engineering solutions to challenging thermal problems such as those that occur in fusion reactors, or high power density electronic systems.
Incorporated in April 2020
Origin: Oxford University, Thermofluids Institute
Contact: Adrian Coles
OxStem Immuno aims to develop small molecule drugs that augment macrophage efferocytosis in
vitro and enhance tissue repair in vivo. These therapies will supercede the need for cell transplantation
or cytokine therapy in the context of tissue repair for chronic wounds and a range of inflammatory
Incorporated in December 2018
Origin: Oxford University, Department of Physiology, Anatomy and Genetics
Contact: Adam Workman